Allergies News and Research

Latest Allergies News and Research

Lineage Therapeutics announces US launch of generic epinephrine auto-injector

Lineage Therapeutics Inc. has announced the US launch of its generic epinephrine injection, USP auto-injector, the authorized generic of Adrenaclick by Amedra Pharmaceuticals LLC, for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis.

15 Jun 2013

EULAR announces recipients of Meritorious Service Award

EULAR today announced the recipients of the 13th annual Meritorious Service Award at the opening of the European League Against Rheumatism Annual Congress.

14 Jun 2013

Value of vaccinating children, young adults for influenza underestimated, experts say

The huge value of vaccinating more children and young adults for influenza is being seriously underestimated, experts say in a new report, while conventional wisdom and historic vaccine programs have concentrated on the elderly and those at higher risk of death and serious complications.

13 Jun 2013

Researchers to launch Phase II clinical trial to investigate potential new therapy for sickle cell anemia

Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana-Farber/Children's Hospital Cancer Center in Boston and the BloodCenter of Wisconsin in Milwaukee and others are preparing to launch Phase II of a clinical trial to investigate a potential new therapy for reducing the disorder's severest symptoms.

12 Jun 2013

Neuromodulators provide guidelines for implantation of "digital drugs" to manage chronic pain

Neuromodulators have joined together in the Neuromodulation Appropriateness Consensus Committee (NACC) to provide the first coordinated set of recommendations about patient selection and appropriateness for implantation of "digital drugs" to manage chronic pain.

12 Jun 2013

New Australian research shows evidence for pre-birth programming of food allergies

Among the many new findings presented at the EAACI-WAO World Allergy and Asthma Congress 2013 in Milan from 22-26 June 2013 is new Australian research providing proof for pre-birth programming of food allergies, showing that prenatal environmental factors may already determine predispositions for food allergies rather than only genetic factors.

7 Jun 2013

HSV-1 exploits immune system receptor to boost infectivity and cause disease

Researchers at the University of California, San Diego School of Medicine and colleagues report that the herpes simplex virus type-1 (HSV-1), which affects an estimated 50 to 80 percent of all American adults, exploits an immune system receptor to boost its infectivity and ability to cause disease.

7 Jun 2013

Research reveals how HIV triggers signal to kill infected immune cell

Untreated HIV infection destroys a person's immune system by killing infection-fighting cells, but precisely when and how HIV wreaks this destruction has been a mystery until now. New research by scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, reveals how HIV triggers a signal telling an infected immune cell to die.

6 Jun 2013

Solid formulations of the recombinant anthrax vaccine: an interview with Dr Mark Carnegie-Brown, CEO, Glide Pharma

Anthrax vaccines have a prominent place in the history of medicine. This goes back to, Pasteur, who while everybody associates with the milk treatment process, also worked on rabies and Anthrax vaccines in cattle.

6 Jun 2013

Allergic rhinitis treatments: an interview with Dr Dermot Ryan, GP and allergy expert

Allergic rhinitis is most commonly recognized as hay fever in the United Kingdom and it is due to the impact of an allergen, in the case of hay fever a pollen, setting off an inflammatory response in the lungs, causing typical symptoms...

5 Jun 2013

New plug-in optical sensor can help diagnose Kaposi's sarcoma

As antiretroviral drugs that treat HIV have become more commonplace, the incidence of Kaposi's sarcoma, a type of cancer linked to AIDS, has decreased in the United States.

5 Jun 2013

Smoke exposure puts infants with respiratory infections at risk for longer hospital stays

More evidence has surfaced that supports the war on smoking, especially if smokers have an infant in their household. A study published today in the June issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI), found that infants with a family history of allergic disease with lower respiratory tract infections, who are exposed to secondhand smoke are at risk for longer hospital stays.

5 Jun 2013

Duke University is awarded $2M to initiate new clinical research network on antibacterial resistance

Duke University, Durham, N.C., has been awarded $2 million to initiate a new clinical research network focused on antibacterial resistance. Total funding for the leadership group cooperative agreement award could reach up to $62 million through 2019.

4 Jun 2013

New copper-nickel coins can increase allergic reactions four fold

In a bid to save -10 million a year the British Treasury is replacing copper-nickel five and ten pence coins with new nickel-plated steel versions. However, while no UK health assessment has taken place, scientists in Sweden have analyzed the allergy risk after the Swedish state bank announced it will reduce traces of nickel in Swedish coinage.

4 Jun 2013

Duke Medicine, UCSF investigators to oversee research program on antibacterial resistance

Investigators at Duke Medicine and the University of California, San Francisco have been selected to oversee a nationwide research program on antibacterial resistance, which includes a focus on the growing unmet challenges associated with methicillin-resistant Staphylococcus aureus and E. coli.

4 Jun 2013

BACH2 gene may play a central role in the development of allergic and autoimmune diseases

Scientists at the National Institutes of Health, and their colleagues, have discovered that a gene called BACH2 may play a central role in the development of diverse allergic and autoimmune diseases, such as multiple sclerosis, asthma, Crohn's disease, celiac disease, and type-1 diabetes.

4 Jun 2013

AANMA offers family-friendly tips to beat the heat and humidity in home

Summer heat goes hand-in-hand with humidity – but it doesn't have to dampen your spirits or take your breath away. Leading nonprofit patient education organization Allergy & Asthma Network Mothers of Asthmatics offers low-cost, family-friendly tips for improving the air in your home.

4 Jun 2013

Activ8rlives 2.0 goes live with new self monitoring capabilities for health and wellness

Activ8rlives’ website version 2.0 has now gone live after several months of preparation and testing. Activ8rlives focuses its online self monitoring solutions for health and wellness, which is utilized by families, groups and companies.

3 Jun 2013

Mintel reports that cold, flu and allergy remedies market increased 22% from 2007-12

With allergy season upon us, the remedies aisle in the drugstore is a familiar location for many Americans. Revealing just how many consumers are affected, more than one-third (36%) of Americans say they experience the misery of allergies and are in need of a cure from the sniffles and sneezes.

1 Jun 2013

Ragweed allergy sublingual immunotherapy: an interview with Dr. Peter Creticos, Johns Hopkins University School of Medicine

Ragweed is a dominant seasonal allergen in North America (~26% of US and North American population is allergic to this noxious weed which pollinates from early August to early October).

31 May 2013

Allergies News and Research

Latest Allergies News and Research

Lineage Therapeutics announces US launch of generic epinephrine auto-injector

EULAR announces recipients of Meritorious Service Award

Value of vaccinating children, young adults for influenza underestimated, experts say

Researchers to launch Phase II clinical trial to investigate potential new therapy for sickle cell anemia

Neuromodulators provide guidelines for implantation of "digital drugs" to manage chronic pain

New Australian research shows evidence for pre-birth programming of food allergies

HSV-1 exploits immune system receptor to boost infectivity and cause disease

Research reveals how HIV triggers signal to kill infected immune cell

Solid formulations of the recombinant anthrax vaccine: an interview with Dr Mark Carnegie-Brown, CEO, Glide Pharma

Allergic rhinitis treatments: an interview with Dr Dermot Ryan, GP and allergy expert

New plug-in optical sensor can help diagnose Kaposi's sarcoma

Smoke exposure puts infants with respiratory infections at risk for longer hospital stays

Duke University is awarded $2M to initiate new clinical research network on antibacterial resistance

New copper-nickel coins can increase allergic reactions four fold

Duke Medicine, UCSF investigators to oversee research program on antibacterial resistance

BACH2 gene may play a central role in the development of allergic and autoimmune diseases

AANMA offers family-friendly tips to beat the heat and humidity in home

Activ8rlives 2.0 goes live with new self monitoring capabilities for health and wellness

Mintel reports that cold, flu and allergy remedies market increased 22% from 2007-12

Ragweed allergy sublingual immunotherapy: an interview with Dr. Peter Creticos, Johns Hopkins University School of Medicine

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Allergies News and Research

Latest Allergies News and Research

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in